

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 8.53359573 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.46106839 |
| 3 | NADH metabolic process (GO:0006734) | 7.30549875 |
| 4 | lipoprotein transport (GO:0042953) | 7.04734739 |
| 5 | * regulation of guanylate cyclase activity (GO:0031282) | 6.31362217 |
| 6 | fructose metabolic process (GO:0006000) | 5.79085804 |
| 7 | angiotensin maturation (GO:0002003) | 5.57919906 |
| 8 | regulation of bile acid biosynthetic process (GO:0070857) | 5.51548344 |
| 9 | opsonization (GO:0008228) | 5.39552094 |
| 10 | drug metabolic process (GO:0017144) | 5.39370308 |
| 11 | positive regulation of hair follicle development (GO:0051798) | 5.38994245 |
| 12 | positive regulation of hair cycle (GO:0042635) | 5.38994245 |
| 13 | hormone catabolic process (GO:0042447) | 5.38169485 |
| 14 | regulation of triglyceride catabolic process (GO:0010896) | 5.35295828 |
| 15 | regulation of systemic arterial blood pressure (GO:0003073) | 5.29700827 |
| 16 | vitamin A metabolic process (GO:0006776) | 5.14583401 |
| 17 | regulation of transforming growth factor beta2 production (GO:0032909) | 5.02911096 |
| 18 | regulation of cardioblast differentiation (GO:0051890) | 4.95469087 |
| 19 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.92369516 |
| 20 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 4.88837661 |
| 21 | cellular glucuronidation (GO:0052695) | 4.86586784 |
| 22 | drug transmembrane transport (GO:0006855) | 4.83162325 |
| 23 | intestinal absorption (GO:0050892) | 4.81023263 |
| 24 | glucuronate metabolic process (GO:0019585) | 4.78513321 |
| 25 | uronic acid metabolic process (GO:0006063) | 4.78513321 |
| 26 | diacylglycerol metabolic process (GO:0046339) | 4.73002913 |
| 27 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.69376330 |
| 28 | response to hydroperoxide (GO:0033194) | 4.66299963 |
| 29 | negative regulation of complement activation (GO:0045916) | 4.54194083 |
| 30 | peptide hormone processing (GO:0016486) | 4.40772895 |
| 31 | hydrogen peroxide catabolic process (GO:0042744) | 4.40330873 |
| 32 | urate metabolic process (GO:0046415) | 4.39290757 |
| 33 | plasma lipoprotein particle assembly (GO:0034377) | 4.34557906 |
| 34 | gland morphogenesis (GO:0022612) | 4.33056504 |
| 35 | urea cycle (GO:0000050) | 4.30862495 |
| 36 | digestion (GO:0007586) | 4.30510963 |
| 37 | drug transport (GO:0015893) | 4.27498154 |
| 38 | regulation of vitamin metabolic process (GO:0030656) | 4.21089906 |
| 39 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.18848793 |
| 40 | regulation of cellular extravasation (GO:0002691) | 4.17876240 |
| 41 | urea metabolic process (GO:0019627) | 4.17828650 |
| 42 | vitamin transmembrane transport (GO:0035461) | 4.17029186 |
| 43 | peptide catabolic process (GO:0043171) | 4.15922838 |
| 44 | regulation of alkaline phosphatase activity (GO:0010692) | 4.15285598 |
| 45 | cellular response to nitric oxide (GO:0071732) | 4.13089362 |
| 46 | intestinal cholesterol absorption (GO:0030299) | 4.10580536 |
| 47 | sulfate transmembrane transport (GO:1902358) | 4.10375329 |
| 48 | glucocorticoid biosynthetic process (GO:0006704) | 4.05510562 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 4.03095282 |
| 50 | actin filament depolymerization (GO:0030042) | 4.02610658 |
| 51 | * positive regulation of guanylate cyclase activity (GO:0031284) | 3.97026389 |
| 52 | glycolipid catabolic process (GO:0019377) | 3.96197223 |
| 53 | regulation of macrophage cytokine production (GO:0010935) | 3.95559271 |
| 54 | cardiac muscle cell proliferation (GO:0060038) | 3.94752265 |
| 55 | protein-lipid complex assembly (GO:0065005) | 3.94585928 |
| 56 | vitamin transport (GO:0051180) | 3.93148200 |
| 57 | lysine catabolic process (GO:0006554) | 3.91121644 |
| 58 | lysine metabolic process (GO:0006553) | 3.91121644 |
| 59 | alkaloid metabolic process (GO:0009820) | 3.90482630 |
| 60 | glycosphingolipid catabolic process (GO:0046479) | 3.88365463 |
| 61 | drinking behavior (GO:0042756) | 3.88301094 |
| 62 | drug catabolic process (GO:0042737) | 3.86803611 |
| 63 | regulation of hair follicle development (GO:0051797) | 3.86707814 |
| 64 | dopamine biosynthetic process (GO:0042416) | 3.86180090 |
| 65 | nitrogen cycle metabolic process (GO:0071941) | 3.84146770 |
| 66 | adhesion of symbiont to host cell (GO:0044650) | 3.79730442 |
| 67 | virion attachment to host cell (GO:0019062) | 3.79730442 |
| 68 | negative regulation of protein activation cascade (GO:2000258) | 3.78509252 |
| 69 | phospholipid efflux (GO:0033700) | 3.77668519 |
| 70 | regulation of respiratory burst (GO:0060263) | 3.74337283 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 3.71054596 |
| 72 | vitamin biosynthetic process (GO:0009110) | 3.66737504 |
| 73 | * regulation of cGMP biosynthetic process (GO:0030826) | 3.65208927 |
| 74 | vitamin D metabolic process (GO:0042359) | 3.63859220 |
| 75 | positive regulation of pseudopodium assembly (GO:0031274) | 3.63275152 |
| 76 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.62723465 |
| 77 | regulation of apoptotic cell clearance (GO:2000425) | 3.61355780 |
| 78 | positive regulation of lipid catabolic process (GO:0050996) | 3.60844357 |
| 79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60078839 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60078839 |
| 81 | embryonic digestive tract development (GO:0048566) | 3.59926160 |
| 82 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.57073218 |
| 83 | positive regulation of macrophage activation (GO:0043032) | 3.56184526 |
| 84 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.55968742 |
| 85 | response to nitric oxide (GO:0071731) | 3.55702525 |
| 86 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.55187476 |
| 87 | sulfate transport (GO:0008272) | 3.52120611 |
| 88 | positive regulation of T cell apoptotic process (GO:0070234) | 3.50489108 |
| 89 | positive regulation of epidermis development (GO:0045684) | 3.49623767 |
| 90 | cellular response to reactive nitrogen species (GO:1902170) | 3.49455539 |
| 91 | cysteine metabolic process (GO:0006534) | 3.49374818 |
| 92 | modified amino acid transport (GO:0072337) | 3.49119426 |
| 93 | cGMP-mediated signaling (GO:0019934) | 3.48814083 |
| 94 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.48550252 |
| 95 | positive regulation of odontogenesis (GO:0042482) | 3.48018723 |
| 96 | glial cell migration (GO:0008347) | 3.46584289 |
| 97 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.45661537 |
| 98 | glutathione biosynthetic process (GO:0006750) | 3.42049247 |
| 99 | sulfur compound transport (GO:0072348) | 3.40370595 |
| 100 | organic cation transport (GO:0015695) | 3.39504053 |
| 101 | quinone biosynthetic process (GO:1901663) | 3.37902441 |
| 102 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.37895636 |
| 103 | cobalamin metabolic process (GO:0009235) | 3.37695702 |
| 104 | bile acid metabolic process (GO:0008206) | 3.35132401 |
| 105 | antibacterial humoral response (GO:0019731) | 3.33665003 |
| 106 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.32176331 |
| 107 | trivalent inorganic anion homeostasis (GO:0072506) | 3.31857364 |
| 108 | phosphate ion homeostasis (GO:0055062) | 3.31857364 |
| 109 | sphingomyelin metabolic process (GO:0006684) | 3.28687668 |
| 110 | phosphate ion transport (GO:0006817) | 3.28478179 |
| 111 | antimicrobial humoral response (GO:0019730) | 3.27485955 |
| 112 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.27419764 |
| 113 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.26888904 |
| 114 | basement membrane organization (GO:0071711) | 3.26568857 |
| 115 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.26004012 |
| 116 | regulation of pseudopodium assembly (GO:0031272) | 3.24618475 |
| 117 | glycerol metabolic process (GO:0006071) | 3.22583355 |
| 118 | glycosylceramide metabolic process (GO:0006677) | 3.22318805 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 3.21768767 |
| 120 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.21509797 |
| 121 | polyol transport (GO:0015791) | 3.17792645 |
| 122 | high-density lipoprotein particle remodeling (GO:0034375) | 3.17316526 |
| 123 | digestive system process (GO:0022600) | 3.17093070 |
| 124 | leukotriene metabolic process (GO:0006691) | 3.17067967 |
| 125 | ovulation from ovarian follicle (GO:0001542) | 3.16080017 |
| 126 | renal absorption (GO:0070293) | 3.14470773 |
| 127 | adhesion of symbiont to host (GO:0044406) | 3.13470695 |
| 128 | striated muscle cell proliferation (GO:0014855) | 3.13181094 |
| 129 | transcytosis (GO:0045056) | 3.13079312 |
| 130 | ceramide catabolic process (GO:0046514) | 3.12650161 |
| 131 | * excretion (GO:0007588) | 3.12428765 |
| 132 | cytidine deamination (GO:0009972) | 3.11469291 |
| 133 | cytidine metabolic process (GO:0046087) | 3.11469291 |
| 134 | cytidine catabolic process (GO:0006216) | 3.11469291 |
| 135 | response to phenylpropanoid (GO:0080184) | 3.10296624 |
| 136 | sphingolipid catabolic process (GO:0030149) | 3.09929399 |
| 137 | membrane repolarization during action potential (GO:0086011) | 3.09670274 |
| 138 | regulation of cholesterol homeostasis (GO:2000188) | 3.09477086 |
| 139 | decidualization (GO:0046697) | 3.02391503 |
| 140 | fat-soluble vitamin metabolic process (GO:0006775) | 3.00027588 |
| 141 | phosphate ion transmembrane transport (GO:0035435) | 2.97546458 |
| 142 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.96062442 |
| 143 | flavonoid metabolic process (GO:0009812) | 2.93146822 |
| 144 | negative regulation of humoral immune response (GO:0002921) | 2.92445056 |
| 145 | bile acid and bile salt transport (GO:0015721) | 2.89140767 |
| 146 | surfactant homeostasis (GO:0043129) | 2.88184418 |
| 147 | quaternary ammonium group transport (GO:0015697) | 2.87595463 |
| 148 | hydrogen peroxide metabolic process (GO:0042743) | 2.86867206 |
| 149 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.86866228 |
| 150 | lipoprotein metabolic process (GO:0042157) | 2.84082367 |
| 151 | positive regulation of macrophage differentiation (GO:0045651) | 2.83418989 |
| 152 | collagen fibril organization (GO:0030199) | 2.83337967 |
| 153 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.81177021 |
| 154 | homocysteine metabolic process (GO:0050667) | 2.80793286 |
| 155 | regulation of complement activation (GO:0030449) | 2.78765470 |
| 156 | hypotonic response (GO:0006971) | 2.74439814 |
| 157 | endocrine process (GO:0050886) | 2.74053710 |
| 158 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.74053710 |
| 159 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.74053710 |
| 160 | macrophage activation involved in immune response (GO:0002281) | 2.73342746 |
| 161 | renal system process involved in regulation of blood volume (GO:0001977) | 2.70379195 |
| 162 | cellular modified amino acid catabolic process (GO:0042219) | 2.68848024 |
| 163 | apoptotic cell clearance (GO:0043277) | 2.66700370 |
| 164 | peptide biosynthetic process (GO:0043043) | 2.64787886 |
| 165 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.64661698 |
| 166 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.64527881 |
| 167 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.64389137 |
| 168 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.64357172 |
| 169 | glucocorticoid metabolic process (GO:0008211) | 2.64014036 |
| 170 | positive regulation of p38MAPK cascade (GO:1900745) | 2.63708667 |
| 171 | exogenous drug catabolic process (GO:0042738) | 2.63172316 |
| 172 | transepithelial transport (GO:0070633) | 2.63142727 |
| 173 | muscle cell proliferation (GO:0033002) | 2.59206523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.80745152 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.54943796 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.11520398 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 2.99613266 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.90142326 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.81177916 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79178379 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.69791700 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.69713930 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.68534201 |
| 11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.61345685 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.55993872 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.50894226 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50207375 |
| 15 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.47878396 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.46554441 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.44264075 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.31578511 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.15603435 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.13383946 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.04544271 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.03315956 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.01236313 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93144469 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.85570857 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85334705 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.78736222 |
| 28 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.78079473 |
| 29 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.73237461 |
| 30 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.70197486 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.66099147 |
| 32 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64116591 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62153700 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61364083 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.60314567 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56082235 |
| 37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.54627642 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53660784 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.53385569 |
| 40 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.51952928 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51407978 |
| 42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47159012 |
| 43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39078173 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37767346 |
| 45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36116719 |
| 46 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.32856152 |
| 47 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31893614 |
| 48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30664896 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25799347 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25024126 |
| 51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.24485206 |
| 52 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.22651228 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21595998 |
| 54 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.21410024 |
| 55 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.21073518 |
| 56 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.19539756 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18677817 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.16793703 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.15645486 |
| 60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.15645486 |
| 61 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.14848529 |
| 62 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14465128 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14023295 |
| 64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13701592 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13334648 |
| 66 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.11836673 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10620533 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09510374 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09368507 |
| 70 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.09126051 |
| 71 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08865960 |
| 72 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08155840 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08036356 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07433020 |
| 75 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06477754 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06338940 |
| 77 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05957926 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05915123 |
| 79 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.05257573 |
| 80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04860772 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04629913 |
| 82 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.03793733 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03645296 |
| 84 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03559300 |
| 85 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02888003 |
| 86 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02832874 |
| 87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02308353 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02251267 |
| 89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01942185 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01156327 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00299438 |
| 92 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00007421 |
| 93 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99924114 |
| 94 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99606651 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99472475 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99353051 |
| 97 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99301769 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99211000 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98507339 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97902996 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97519960 |
| 102 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95577686 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95577686 |
| 104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95463075 |
| 105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95463075 |
| 106 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.95017145 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94422101 |
| 108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92538251 |
| 109 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.92456835 |
| 110 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.92264480 |
| 111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91073255 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90860310 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90646560 |
| 114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90553789 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90199474 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90199474 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90044676 |
| 118 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89924260 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89705191 |
| 120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88618752 |
| 121 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88306787 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88255418 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87726483 |
| 124 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87422397 |
| 125 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.87210813 |
| 126 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87188227 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.86505412 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86467238 |
| 129 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.86218702 |
| 130 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85841827 |
| 131 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84980590 |
| 132 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.84842931 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84647315 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84636169 |
| 135 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83974961 |
| 136 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83887743 |
| 137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83282717 |
| 138 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.83233205 |
| 139 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82745304 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81782756 |
| 141 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.80563180 |
| 142 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.80353609 |
| 143 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.80322441 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79717121 |
| 145 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.79251512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.52126925 |
| 2 | MP0002254_reproductive_system_inflammat | 4.46648692 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 4.45705041 |
| 4 | MP0006054_spinal_hemorrhage | 4.30535583 |
| 5 | MP0004147_increased_porphyrin_level | 4.17613702 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 3.68558535 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.67302921 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.23475407 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.19925732 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.12440210 |
| 11 | MP0003252_abnormal_bile_duct | 3.08607972 |
| 12 | MP0000604_amyloidosis | 2.74600240 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.58297402 |
| 14 | MP0001958_emphysema | 2.55797951 |
| 15 | MP0003329_amyloid_beta_deposits | 2.45154622 |
| 16 | MP0000681_abnormal_thyroid_gland | 2.44812820 |
| 17 | * MP0001765_abnormal_ion_homeostasis | 2.41349532 |
| 18 | MP0004043_abnormal_pH_regulation | 2.40753962 |
| 19 | MP0009643_abnormal_urine_homeostasis | 2.36736030 |
| 20 | MP0005332_abnormal_amino_acid | 2.28057523 |
| 21 | MP0003868_abnormal_feces_composition | 2.11021245 |
| 22 | MP0008004_abnormal_stomach_pH | 2.06592584 |
| 23 | MP0005409_darkened_coat_color | 2.00246458 |
| 24 | MP0000490_abnormal_crypts_of | 1.97225210 |
| 25 | * MP0005636_abnormal_mineral_homeostasis | 1.97149694 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 1.93524962 |
| 27 | MP0000538_abnormal_urinary_bladder | 1.88770943 |
| 28 | MP0001756_abnormal_urination | 1.86053024 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.74528849 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.73717679 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.69083076 |
| 32 | MP0005670_abnormal_white_adipose | 1.64795428 |
| 33 | MP0009840_abnormal_foam_cell | 1.64732298 |
| 34 | MP0005085_abnormal_gallbladder_physiolo | 1.62657621 |
| 35 | MP0004272_abnormal_basement_membrane | 1.61698275 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.61282459 |
| 37 | MP0000462_abnormal_digestive_system | 1.60445862 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.58011019 |
| 39 | * MP0002136_abnormal_kidney_physiology | 1.51158335 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.48964584 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.48778717 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.43905892 |
| 43 | MP0004883_abnormal_blood_vessel | 1.43626556 |
| 44 | MP0001188_hyperpigmentation | 1.40730817 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.39124112 |
| 46 | MP0001764_abnormal_homeostasis | 1.36347956 |
| 47 | MP0005275_abnormal_skin_tensile | 1.34464820 |
| 48 | MP0005365_abnormal_bile_salt | 1.33836375 |
| 49 | MP0003879_abnormal_hair_cell | 1.33519778 |
| 50 | * MP0001664_abnormal_digestion | 1.31003593 |
| 51 | MP0005377_hearing/vestibular/ear_phenot | 1.29813487 |
| 52 | MP0003878_abnormal_ear_physiology | 1.29813487 |
| 53 | MP0003718_maternal_effect | 1.29565012 |
| 54 | MP0002822_catalepsy | 1.29502436 |
| 55 | MP0001881_abnormal_mammary_gland | 1.27096442 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.20429073 |
| 57 | MP0001663_abnormal_digestive_system | 1.18610087 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.13229367 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.13212291 |
| 60 | MP0001873_stomach_inflammation | 1.10920843 |
| 61 | MP0005164_abnormal_response_to | 1.08874211 |
| 62 | MP0005448_abnormal_energy_balance | 1.07623979 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 1.03772050 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.02858805 |
| 65 | MP0001849_ear_inflammation | 1.02159533 |
| 66 | MP0004270_analgesia | 1.02141709 |
| 67 | MP0002796_impaired_skin_barrier | 1.01150687 |
| 68 | MP0005535_abnormal_body_temperature | 1.00657308 |
| 69 | MP0005166_decreased_susceptibility_to | 0.98710816 |
| 70 | MP0005451_abnormal_body_composition | 0.95822528 |
| 71 | MP0001501_abnormal_sleep_pattern | 0.95325765 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94145571 |
| 73 | MP0001727_abnormal_embryo_implantation | 0.93023579 |
| 74 | MP0002971_abnormal_brown_adipose | 0.92872910 |
| 75 | MP0001177_atelectasis | 0.92464341 |
| 76 | MP0000249_abnormal_blood_vessel | 0.91781718 |
| 77 | MP0009764_decreased_sensitivity_to | 0.90040005 |
| 78 | MP0002098_abnormal_vibrissa_morphology | 0.88629739 |
| 79 | MP0002135_abnormal_kidney_morphology | 0.88049207 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.87179968 |
| 81 | MP0008872_abnormal_physiological_respon | 0.86393353 |
| 82 | MP0003045_fibrosis | 0.85323223 |
| 83 | MP0003638_abnormal_response/metabolism_ | 0.84999255 |
| 84 | MP0000013_abnormal_adipose_tissue | 0.82852584 |
| 85 | MP0001661_extended_life_span | 0.82447416 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.80429451 |
| 87 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80320311 |
| 88 | * MP0000230_abnormal_systemic_arterial | 0.80287087 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 0.79740542 |
| 90 | MP0009115_abnormal_fat_cell | 0.79150854 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.76992406 |
| 92 | MP0001845_abnormal_inflammatory_respons | 0.74743807 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.74303138 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.73177233 |
| 95 | MP0002396_abnormal_hematopoietic_system | 0.73122124 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.72959546 |
| 97 | MP0003866_abnormal_defecation | 0.71917901 |
| 98 | MP0009785_altered_susceptibility_to | 0.71624867 |
| 99 | MP0000537_abnormal_urethra_morphology | 0.71560274 |
| 100 | MP0000534_abnormal_ureter_morphology | 0.71533064 |
| 101 | MP0000609_abnormal_liver_physiology | 0.71467975 |
| 102 | MP0002896_abnormal_bone_mineralization | 0.71143707 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.70070055 |
| 104 | MP0005501_abnormal_skin_physiology | 0.69291202 |
| 105 | MP0000751_myopathy | 0.68209062 |
| 106 | MP0004742_abnormal_vestibular_system | 0.68050169 |
| 107 | MP0003448_altered_tumor_morphology | 0.67827082 |
| 108 | MP0008469_abnormal_protein_level | 0.64466999 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.64244623 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.63927157 |
| 111 | MP0004858_abnormal_nervous_system | 0.62858366 |
| 112 | MP0004885_abnormal_endolymph | 0.62523200 |
| 113 | MP0004484_altered_response_of | 0.62432633 |
| 114 | MP0001270_distended_abdomen | 0.61756307 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.61126775 |
| 116 | MP0005023_abnormal_wound_healing | 0.60998132 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.60434537 |
| 118 | * MP0009642_abnormal_blood_homeostasis | 0.60081567 |
| 119 | MP0002928_abnormal_bile_duct | 0.59810060 |
| 120 | MP0000627_abnormal_mammary_gland | 0.59659949 |
| 121 | MP0003195_calcinosis | 0.57766247 |
| 122 | MP0002060_abnormal_skin_morphology | 0.57052339 |
| 123 | MP0002115_abnormal_skeleton_extremities | 0.56737599 |
| 124 | MP0003724_increased_susceptibility_to | 0.56725392 |
| 125 | MP0003795_abnormal_bone_structure | 0.56592531 |
| 126 | MP0010155_abnormal_intestine_physiology | 0.55933489 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.55900228 |
| 128 | MP0000858_altered_metastatic_potential | 0.55035783 |
| 129 | MP0005503_abnormal_tendon_morphology | 0.54761281 |
| 130 | MP0002160_abnormal_reproductive_system | 0.54333265 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.54330070 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.53958781 |
| 133 | MP0005334_abnormal_fat_pad | 0.53823621 |
| 134 | MP0003953_abnormal_hormone_level | 0.53171998 |
| 135 | MP0006138_congestive_heart_failure | 0.52398283 |
| 136 | MP0001533_abnormal_skeleton_physiology | 0.51875856 |
| 137 | MP0002168_other_aberrant_phenotype | 0.51861398 |
| 138 | MP0002078_abnormal_glucose_homeostasis | 0.51132569 |
| 139 | MP0002166_altered_tumor_susceptibility | 0.47739818 |
| 140 | MP0003303_peritoneal_inflammation | 0.46874913 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.45314595 |
| 142 | MP0009333_abnormal_splenocyte_physiolog | 0.44816318 |
| 143 | MP0005174_abnormal_tail_pigmentation | 0.44805726 |
| 144 | MP0006082_CNS_inflammation | 0.44725894 |
| 145 | MP0005025_abnormal_response_to | 0.43548133 |
| 146 | MP0000566_synostosis | 0.42503982 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.40144204 |
| 148 | MP0004947_skin_inflammation | 0.39744094 |
| 149 | MP0003436_decreased_susceptibility_to | 0.38814469 |
| 150 | MP0008260_abnormal_autophagy | 0.37051775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arterial tortuosity (HP:0005116) | 6.73913948 |
| 2 | Spondylolisthesis (HP:0003302) | 6.51972391 |
| 3 | Aortic dissection (HP:0002647) | 6.20650963 |
| 4 | Vascular tortuosity (HP:0004948) | 6.06612198 |
| 5 | Malnutrition (HP:0004395) | 5.65594304 |
| 6 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.60669670 |
| 7 | Metabolic alkalosis (HP:0200114) | 5.40676121 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.39306057 |
| 9 | Abnormality of vitamin B metabolism (HP:0004340) | 5.25327725 |
| 10 | Chronic diarrhea (HP:0002028) | 5.21348513 |
| 11 | Confusion (HP:0001289) | 4.99326972 |
| 12 | Fat malabsorption (HP:0002630) | 4.52659621 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.44161521 |
| 14 | Acanthocytosis (HP:0001927) | 4.23402403 |
| 15 | Abnormality of vitamin metabolism (HP:0100508) | 4.21024469 |
| 16 | Aortic aneurysm (HP:0004942) | 4.09869169 |
| 17 | Decreased circulating renin level (HP:0003351) | 3.80204476 |
| 18 | Gout (HP:0001997) | 3.78459568 |
| 19 | Hyperactive renin-angiotensin system (HP:0000841) | 3.77874091 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.70428276 |
| 21 | Nausea (HP:0002018) | 3.65332725 |
| 22 | Pigmentary retinal degeneration (HP:0001146) | 3.61676243 |
| 23 | Abnormality of chloride homeostasis (HP:0011422) | 3.58623268 |
| 24 | Abnormality of renin-angiotensin system (HP:0000847) | 3.50900911 |
| 25 | Abnormality of proline metabolism (HP:0010907) | 3.48668040 |
| 26 | Hydroxyprolinuria (HP:0003080) | 3.48668040 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.44396275 |
| 28 | Hypokalemic alkalosis (HP:0001949) | 3.37550888 |
| 29 | Megaloblastic anemia (HP:0001889) | 3.26551914 |
| 30 | Increased circulating renin level (HP:0000848) | 3.25216706 |
| 31 | Premature rupture of membranes (HP:0001788) | 3.22618886 |
| 32 | Xanthomatosis (HP:0000991) | 3.22050618 |
| 33 | Cerebral aneurysm (HP:0004944) | 3.16565893 |
| 34 | Congenital sensorineural hearing impairment (HP:0008527) | 3.16331155 |
| 35 | Alkalosis (HP:0001948) | 3.15918572 |
| 36 | Hypomagnesemia (HP:0002917) | 3.14893883 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 3.13114222 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.09588890 |
| 39 | Mucopolysacchariduria (HP:0008155) | 3.09588890 |
| 40 | Neoplasm of the heart (HP:0100544) | 3.09399544 |
| 41 | Ulnar bowing (HP:0003031) | 3.02099229 |
| 42 | Abnormality of magnesium homeostasis (HP:0004921) | 3.01701649 |
| 43 | Ileus (HP:0002595) | 3.01587905 |
| 44 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.01311569 |
| 45 | Widely patent fontanelles and sutures (HP:0004492) | 2.97722937 |
| 46 | Hyperparathyroidism (HP:0000843) | 2.97473732 |
| 47 | Steatorrhea (HP:0002570) | 2.96833232 |
| 48 | Abnormal urine output (HP:0012590) | 2.95839223 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.92824283 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.89509223 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.89509223 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.89509223 |
| 53 | Posterior subcapsular cataract (HP:0007787) | 2.87636563 |
| 54 | Hyperuricemia (HP:0002149) | 2.85450395 |
| 55 | Increased purine levels (HP:0004368) | 2.85450395 |
| 56 | Hyperglycinuria (HP:0003108) | 2.83773383 |
| 57 | Thin bony cortex (HP:0002753) | 2.83718912 |
| 58 | Hypophosphatemia (HP:0002148) | 2.83256983 |
| 59 | Hypokalemia (HP:0002900) | 2.83161451 |
| 60 | Gastrointestinal dysmotility (HP:0002579) | 2.82882003 |
| 61 | Abnormality of renal excretion (HP:0011036) | 2.82275259 |
| 62 | Bicuspid aortic valve (HP:0001647) | 2.78909130 |
| 63 | Mitral valve prolapse (HP:0001634) | 2.76150597 |
| 64 | Hypolipoproteinemia (HP:0010981) | 2.73729863 |
| 65 | Enlarged epiphyses (HP:0010580) | 2.71427861 |
| 66 | Ankle contracture (HP:0006466) | 2.68385705 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.68321481 |
| 68 | Facial shape deformation (HP:0011334) | 2.64998048 |
| 69 | Potter facies (HP:0002009) | 2.64998048 |
| 70 | Abnormal urine phosphate concentration (HP:0012599) | 2.63437072 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.63079630 |
| 72 | Hyperammonemia (HP:0001987) | 2.59793139 |
| 73 | Mesangial abnormality (HP:0001966) | 2.59306191 |
| 74 | Right ventricular cardiomyopathy (HP:0011663) | 2.59210131 |
| 75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.55889423 |
| 76 | Petechiae (HP:0000967) | 2.51590503 |
| 77 | Polyuria (HP:0000103) | 2.51349400 |
| 78 | Proximal tubulopathy (HP:0000114) | 2.48362014 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.46859190 |
| 80 | Hypotension (HP:0002615) | 2.43915625 |
| 81 | Hyperaldosteronism (HP:0000859) | 2.43621432 |
| 82 | Hyperphosphaturia (HP:0003109) | 2.42967438 |
| 83 | Renal salt wasting (HP:0000127) | 2.42384492 |
| 84 | Villous atrophy (HP:0011473) | 2.40584455 |
| 85 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.40584455 |
| 86 | Focal segmental glomerulosclerosis (HP:0000097) | 2.38142302 |
| 87 | Abnormality of the costochondral junction (HP:0000919) | 2.37605038 |
| 88 | Tetany (HP:0001281) | 2.33760910 |
| 89 | Metabolic acidosis (HP:0001942) | 2.31115780 |
| 90 | Cervical subluxation (HP:0003308) | 2.30915844 |
| 91 | Purpura (HP:0000979) | 2.27709400 |
| 92 | Persistence of primary teeth (HP:0006335) | 2.25189826 |
| 93 | Flat acetabular roof (HP:0003180) | 2.25095172 |
| 94 | Nephrolithiasis (HP:0000787) | 2.24573741 |
| 95 | Abnormality of nucleobase metabolism (HP:0010932) | 2.23876726 |
| 96 | Eczematoid dermatitis (HP:0000976) | 2.20557836 |
| 97 | Protuberant abdomen (HP:0001538) | 2.20108162 |
| 98 | Radial bowing (HP:0002986) | 2.18086780 |
| 99 | Renal tubular acidosis (HP:0001947) | 2.16804881 |
| 100 | Glycosuria (HP:0003076) | 2.14510374 |
| 101 | Abnormality of urine glucose concentration (HP:0011016) | 2.14510374 |
| 102 | Subcapsular cataract (HP:0000523) | 2.12751247 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.10234134 |
| 104 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10234134 |
| 105 | Cerebral palsy (HP:0100021) | 2.08533091 |
| 106 | Epidermoid cyst (HP:0200040) | 2.08314399 |
| 107 | Delayed epiphyseal ossification (HP:0002663) | 2.08250514 |
| 108 | Thyroid-stimulating hormone excess (HP:0002925) | 2.07501879 |
| 109 | Spastic diplegia (HP:0001264) | 2.05980833 |
| 110 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.03975364 |
| 111 | Abnormality of potassium homeostasis (HP:0011042) | 2.03943638 |
| 112 | Abnormality of glycine metabolism (HP:0010895) | 2.03896250 |
| 113 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.03896250 |
| 114 | Abnormality of abdominal situs (HP:0011620) | 2.01690439 |
| 115 | Abdominal situs inversus (HP:0003363) | 2.01690439 |
| 116 | Dehydration (HP:0001944) | 2.01091940 |
| 117 | Ketoacidosis (HP:0001993) | 2.00084779 |
| 118 | Glomerulonephritis (HP:0000099) | 1.99936799 |
| 119 | Hyperphosphatemia (HP:0002905) | 1.97350132 |
| 120 | Hypercalciuria (HP:0002150) | 1.97067906 |
| 121 | Wide cranial sutures (HP:0010537) | 1.95520523 |
| 122 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.95341119 |
| 123 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.93005768 |
| 124 | Fragile skin (HP:0001030) | 1.92222421 |
| 125 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91576700 |
| 126 | Conjugated hyperbilirubinemia (HP:0002908) | 1.90909195 |
| 127 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.90802843 |
| 128 | Renal tubular dysfunction (HP:0000124) | 1.90737937 |
| 129 | Bowing of the arm (HP:0006488) | 1.90154898 |
| 130 | Bowed forearm bones (HP:0003956) | 1.90154898 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89875823 |
| 132 | Osteolytic defects of the hand bones (HP:0009699) | 1.89875823 |
| 133 | Nephritis (HP:0000123) | 1.89793457 |
| 134 | Growth hormone excess (HP:0000845) | 1.88963734 |
| 135 | Pancreatitis (HP:0001733) | 1.88562611 |
| 136 | Abdominal distention (HP:0003270) | 1.88099648 |
| 137 | Multiple lipomas (HP:0001012) | 1.87748340 |
| 138 | Type 1 muscle fiber predominance (HP:0003803) | 1.86919329 |
| 139 | Abnormal glucose tolerance (HP:0001952) | 1.84824178 |
| 140 | Poikilocytosis (HP:0004447) | 1.84568511 |
| 141 | Ventricular fibrillation (HP:0001663) | 1.83087880 |
| 142 | Abnormal drinking behavior (HP:0030082) | 1.83021703 |
| 143 | Polydipsia (HP:0001959) | 1.83021703 |
| 144 | Irritability (HP:0000737) | 1.82881286 |
| 145 | Pili torti (HP:0003777) | 1.82822495 |
| 146 | Gingivitis (HP:0000230) | 1.79507970 |
| 147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77048213 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76633888 |
| 149 | Asymmetric septal hypertrophy (HP:0001670) | 1.76505482 |
| 150 | Glomerulosclerosis (HP:0000096) | 1.76076366 |
| 151 | Arachnodactyly (HP:0001166) | 1.76034040 |
| 152 | Broad metatarsal (HP:0001783) | 1.74188116 |
| 153 | Aneurysm (HP:0002617) | 1.73926568 |
| 154 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.67572007 |
| 155 | Abnormal albumin level (HP:0012116) | 1.64901049 |
| 156 | Hypoalbuminemia (HP:0003073) | 1.64901049 |
| 157 | Metaphyseal irregularity (HP:0003025) | 1.64867706 |
| 158 | Lethargy (HP:0001254) | 1.63526366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 9.67082650 |
| 2 | MYLK | 4.66973156 |
| 3 | TGFBR2 | 4.17394209 |
| 4 | WNK4 | 3.45878677 |
| 5 | MST1R | 3.42132580 |
| 6 | TTN | 3.16043984 |
| 7 | MST4 | 3.12702625 |
| 8 | WNK3 | 3.10203598 |
| 9 | OXSR1 | 2.85555507 |
| 10 | ERN1 | 2.84669243 |
| 11 | LMTK2 | 2.55910885 |
| 12 | FRK | 2.21517149 |
| 13 | EPHB1 | 2.02997770 |
| 14 | TAOK3 | 1.93284037 |
| 15 | TESK2 | 1.87164521 |
| 16 | PIK3CG | 1.83544359 |
| 17 | MAPKAPK3 | 1.83461803 |
| 18 | MET | 1.83298414 |
| 19 | MAP3K10 | 1.82941561 |
| 20 | PIK3CA | 1.76278657 |
| 21 | RIPK1 | 1.73958793 |
| 22 | PTK6 | 1.66819441 |
| 23 | DMPK | 1.62081632 |
| 24 | PRKG2 | 1.50790219 |
| 25 | PDGFRA | 1.49924421 |
| 26 | NME1 | 1.47265477 |
| 27 | EPHB2 | 1.46406976 |
| 28 | PDK2 | 1.45749068 |
| 29 | PAK2 | 1.45706634 |
| 30 | GRK6 | 1.45032241 |
| 31 | MAP3K12 | 1.41709117 |
| 32 | LRRK2 | 1.40939266 |
| 33 | PTK2 | 1.40607420 |
| 34 | TESK1 | 1.38966934 |
| 35 | MAP3K2 | 1.38654332 |
| 36 | PAK4 | 1.35147366 |
| 37 | STK39 | 1.32338694 |
| 38 | EPHA4 | 1.31301185 |
| 39 | TRIB3 | 1.29399978 |
| 40 | DDR2 | 1.28163468 |
| 41 | TNIK | 1.20614520 |
| 42 | FER | 1.20460805 |
| 43 | STK38 | 1.14803518 |
| 44 | MAP4K1 | 1.14535249 |
| 45 | MAP3K7 | 1.12801304 |
| 46 | DAPK2 | 1.07011572 |
| 47 | RIPK4 | 1.06608847 |
| 48 | CASK | 1.01661871 |
| 49 | MATK | 1.01525114 |
| 50 | FGFR4 | 1.00820973 |
| 51 | STK24 | 0.96917728 |
| 52 | MAP2K6 | 0.95503786 |
| 53 | FGFR2 | 0.89456884 |
| 54 | PTK2B | 0.87682356 |
| 55 | PDPK1 | 0.87366650 |
| 56 | LATS1 | 0.85909003 |
| 57 | PRPF4B | 0.85630425 |
| 58 | NTRK1 | 0.85298344 |
| 59 | STK10 | 0.85046017 |
| 60 | MAP2K2 | 0.84727993 |
| 61 | MAP3K11 | 0.83004451 |
| 62 | ERBB2 | 0.81624859 |
| 63 | BMX | 0.79996968 |
| 64 | KDR | 0.74747049 |
| 65 | LIMK1 | 0.73290447 |
| 66 | PAK3 | 0.73222584 |
| 67 | DYRK1B | 0.69751426 |
| 68 | PAK1 | 0.69524507 |
| 69 | PIM1 | 0.69167230 |
| 70 | STK38L | 0.69006452 |
| 71 | CDC42BPA | 0.68747159 |
| 72 | ROCK1 | 0.68725200 |
| 73 | PRKACG | 0.68207123 |
| 74 | SGK494 | 0.67868546 |
| 75 | SGK223 | 0.67868546 |
| 76 | GSK3A | 0.66329796 |
| 77 | PRKCZ | 0.61402861 |
| 78 | AKT3 | 0.60941188 |
| 79 | TIE1 | 0.60747370 |
| 80 | SGK3 | 0.60683392 |
| 81 | MAPK11 | 0.58863457 |
| 82 | MAP3K1 | 0.56642942 |
| 83 | PRKCI | 0.54964836 |
| 84 | ABL2 | 0.54538599 |
| 85 | PDK4 | 0.52692466 |
| 86 | PDK3 | 0.52692466 |
| 87 | PKN2 | 0.51529406 |
| 88 | SRC | 0.51471394 |
| 89 | KSR2 | 0.51061496 |
| 90 | TYK2 | 0.50794104 |
| 91 | GRK1 | 0.50165232 |
| 92 | PDK1 | 0.49982889 |
| 93 | MAP3K3 | 0.49613020 |
| 94 | WNK1 | 0.47205513 |
| 95 | CAMK2D | 0.46260586 |
| 96 | FGFR3 | 0.45857088 |
| 97 | BCKDK | 0.45039947 |
| 98 | NLK | 0.44836632 |
| 99 | ROCK2 | 0.43158547 |
| 100 | IRAK3 | 0.41925050 |
| 101 | NUAK1 | 0.40598726 |
| 102 | STK3 | 0.39715483 |
| 103 | DAPK3 | 0.38785079 |
| 104 | EPHA3 | 0.38040433 |
| 105 | CSF1R | 0.36686518 |
| 106 | PRKCD | 0.36442128 |
| 107 | PRKAA2 | 0.36270350 |
| 108 | JAK3 | 0.35885268 |
| 109 | MAPK12 | 0.34274635 |
| 110 | EPHA2 | 0.33673615 |
| 111 | MELK | 0.33568696 |
| 112 | MAP2K1 | 0.33324149 |
| 113 | PRKD1 | 0.32048328 |
| 114 | PDGFRB | 0.31535824 |
| 115 | NEK1 | 0.30823245 |
| 116 | ITK | 0.30724950 |
| 117 | BMPR2 | 0.29554735 |
| 118 | JAK2 | 0.28607793 |
| 119 | RET | 0.28290084 |
| 120 | MAP3K8 | 0.27642707 |
| 121 | YES1 | 0.27099612 |
| 122 | TBK1 | 0.26655167 |
| 123 | BMPR1B | 0.26544565 |
| 124 | TEC | 0.26188514 |
| 125 | TAOK1 | 0.25340306 |
| 126 | JAK1 | 0.25291864 |
| 127 | CSK | 0.24735551 |
| 128 | FYN | 0.24107955 |
| 129 | CDK19 | 0.23898928 |
| 130 | CAMK2G | 0.23454726 |
| 131 | MAPK4 | 0.23151541 |
| 132 | ILK | 0.22399571 |
| 133 | NEK9 | 0.22385672 |
| 134 | SYK | 0.21813806 |
| 135 | RPS6KA2 | 0.21478435 |
| 136 | PRKCA | 0.21137572 |
| 137 | BTK | 0.21072448 |
| 138 | EEF2K | 0.20195535 |
| 139 | IRAK1 | 0.20140839 |
| 140 | NEK6 | 0.19832712 |
| 141 | LYN | 0.19624634 |
| 142 | CSNK1A1 | 0.17774828 |
| 143 | CAMK2B | 0.17709661 |
| 144 | PIM2 | 0.17684501 |
| 145 | IKBKE | 0.17579327 |
| 146 | CAMK2A | 0.17335851 |
| 147 | CAMKK1 | 0.16851285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.42706846 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.23241826 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.74411417 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.71303451 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 2.58277063 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.49389540 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.44287274 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 2.24750383 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22135932 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18510484 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12907439 |
| 12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.04713634 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.93858438 |
| 14 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.93623941 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89819772 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86650475 |
| 17 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.78084537 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.76890553 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.72015641 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.64744768 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64541145 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62723905 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59965469 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54912540 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.54639259 |
| 26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.43501529 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42585569 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41750490 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41613722 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36303775 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.33081999 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.32717120 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31801106 |
| 34 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.28678357 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.26995239 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26921113 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26651103 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24911361 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23253673 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.18743987 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13268404 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13188668 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06225235 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04031978 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02658784 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02063932 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00090812 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98661689 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.98140657 |
| 50 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96959550 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96700923 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95305427 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.91586642 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90833963 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90742477 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90402570 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89569841 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87460892 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87155383 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86554678 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84525189 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79791968 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76829027 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74893004 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74110983 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72517978 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72305077 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.71837057 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70681685 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69439525 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66947000 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65873905 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65552938 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.63960168 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.63825818 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63312229 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62139228 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60788685 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.60449888 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57992651 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.57012910 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54789298 |
| 83 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53536910 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51871925 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51764357 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51159600 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50262220 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50186446 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49615567 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47654327 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47193767 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.45128715 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45083581 |
| 94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43288797 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.41496950 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.41266057 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.40385329 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.40374162 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40204538 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38222253 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38025741 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37726378 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37396519 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.37316818 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.36488423 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.34645663 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34065458 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33885176 |
| 109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.33480315 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33445954 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33322406 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31769654 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31649160 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28650414 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27172549 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26807909 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.26102191 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24316379 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23973387 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.19200918 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.19125534 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16774157 |
| 123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.14421049 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.13005601 |
| 125 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10448239 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.08555080 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04332452 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03936522 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.03674502 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.03534337 |
| 131 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.02027407 |
| 132 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.01355628 |
| 133 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00899359 |

